(Q57905095)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1 reference

1 reference

Athanasios Dimopoulos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

V Georgoulias

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

N Androulakis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

C Kourousis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S Kakolyris

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

E Papadakis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

F Apostolopoulou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

C Papadimitriou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Vossos

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M Agelidou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

P Heras

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S Tzannes

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J Vlachonicolis

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

E Mavromanolakis

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

D Hatzidaki

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

331-334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

Relationships between the structure of taxol analogs and their antimitotic activity

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008278103446

7 January 2021

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008278103446

7 January 2021

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008278103446

7 January 2021

Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008278103446

7 January 2021

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008278103446

7 January 2021

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008278103446

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008278103446

7 January 2021

Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008278103446

7 January 2021

Identifiers

DOI

10.1023/A:1008278103446

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602269%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference